MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2023 International Congress

August 27-31, 2023. Copenhagen, Denmark.

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Drooling is associated with disease severity in Parkinson’s disease

    N. Nishikawa, E. Ikami, H. Takeshige, T. Ogawa, T. Hatano, N. Hattori (Tokyo, Japan)

  • Drug-induced Parkinsonism and nonmotor symptoms: a case of gustatory rhinorrhea

    S. Casanova, A. Cabral, M. Branco (Vila Nova Gaia, Portugal)

  • Dry Cleaning Chemicals and Parkinson’s Disease

    M. Pawlik, S. Lettenberger, M. Zafar, P. Auinger, K. Hylton, M. Coffey, S. Goldman, B. de Miranda, K. Kieburtz, H. Schwarz, R. Barbano, M. Braun, J. Adams, D. Kinel, R. Dorsey (Rochester, USA)

  • Dual globus pallidus internus and subthalamic nucleus deep brain stimulation for medically refractory craniocervical dystonia: a case report

    C. Swan, S. Sani, N. Patel (Chicago, USA)

  • Dynamic assessment of levels of depression and anxiety impairment in Parkinson’s disease

    O. Naimov, R. Matmurodov (Tashkent, Uzbekistan)

  • Dysconnectivity of the Parafascicular Nucleus in Parkinson’s Disease

    L. Chen, T. Wu (Beijing, China)

  • Dysconnectivity Profiles of Raphe Nuclei in Parkinson’s Disease: From Prodromal to Advanced Stage

    W. Junling, S. Junyan, Z. Dongling, C. Lili, W. Tao (Beijing, China)

  • Dyskinesia and adherence to safinamide and opicapone in fluctuating patients with Parkinson’s disease: observational retrospective study

    P. Lorenzo-Barreto, I. Pareés, P. Pérez-Torre, S. Fanjul, JL. López-Sendón, F. Pérez-Trapote, A. Sáez-Marín, E. Stiauren-Fernández, á. Patiño-Patón, JC. Martínez-Castrillo, A. Alonso-Cánovas (Madrid, Spain)

  • Dysphagia and dopaminergic neurodegeneration in Parkinson’s Disease

    S. Polychronis, B. Ribba, G. Nasios, E. Dardiotis, G. Pagano (Ioannina, Greece)

  • Dysphagia in Parkinson’s disease

    M. Carmona-Abellan, A. Ibargutxi, E. Gómez, N. Zuza, B. Díez-Arrola, K. Berganzo, C. Garcia-Monco, J. Zabala, A. Bilbao, U. Pequeño (Bilbao, Spain)

  • « Previous Page
  • 1
  • …
  • 58
  • 59
  • 60
  • 61
  • 62
  • …
  • 186
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Patients with Essential Tremor Live Longer than their Relatives
  • #23624 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Three cases of early tremor in the course of Guillain-Barré Syndrome
  • The impact of gastric acid suppressants and antacids on levodopa plasma concentration in patients with Parkinson’s disease
  • To be or not to bupropion: a drug-induced parkinsonism?
  • The Role of MRI and DaTscan in Vascular Parkinsonism: A Case Report
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley